Egil Bodd is a medical doctor and holds a PhD in pharmacology from the University of Oslo, Norway. From 2006-2015, Egil was the Managing Partner of Lindsay Goldberg Nordic, the Nordic affiliate of the New York based private equity firm Lindsay Goldberg.

From 2004-2006 Egil was the CEO of Pronova Biocare. From 1992-2003, Egil held various leadership positions in the global pharmaceutical company Merck & Co. In his last position, as Managing Director, Vice President of EMEA. From 1986-1992 Egil was President of the TTO Medinnova.

In addition, Egil has held various healthcare responsibilities, including: chairman of the Norwegian Society of Pharmacology and Toxicology, chairman of the Norwegian Committee of Pharmacovigilance (reporting to the Director of Health), chairman of the Norwegian Pharmaceutical Industry Association, member of the supervisory board and chairman of the scientific committee at Lundbeck; and member of the board of the Medical Faculty at the University of Oslo.